Current Affairs

DCGI The Drug Controller General of India has granted approval to Hetero pharmaceutical company for the treatment of covid19 patients


Daily Current Affairs


DCGI The Drug Controller General of India has granted approval to Hetero pharmaceutical company for the treatment of covid19 patients

 

DCGI The Drug Controller General of India has granted approval to Hetero pharmaceutical company for the treatment of covid19 patients of adults, children, hospitalized with severe symptoms of the diseases. Hetero Pharmaceutical company began marketing and manufacturing of the investigational antiviral medicine “Remdesivir” with the brand name of “COVIFOR” in India. COVIFOR is a generic medicine that can prove a game-changer to positive clinical cases.

Highlights:

·         The COVIFOR (Remdesivir) will be made available in 100 mg injectable antiviral drug has to be administered intravenously in a hospital setting under the supervision of a medical practitioner.

·         Total number of cases of coronavirus reached 411621 with a record of 16021 cases in the last 24 hours. However, the number of patients recovering from covid19 in India continues to increase. There are 55.49 percent registered cases amongst the covid19 patients. 


Daily Current Affairs

Also Read Current Affairs in Tamil, Current Affairs in English, Download Current pdf in Tamil, Download Current Affairs in English, Upcoming Jobs            

DCGI The Drug Controller General of India has granted approval to Hetero pharmaceutical company for the treatment of covid19 patients